Moderna shares COVID-19 vaccine trial blueprints, will others follow?

1 Comment
By Ivan Couronne

The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.

© 2020 AFP

©2020 GPlusMedia Inc.

1 Comment
Login to comment

Registered protocols are already a requirement for clinical trials, making them open to the public is just a small extra step that should not be difficult to make.

The only problem would be to make open preliminary results, because that brings unnecessary pressures that can bias the rest of the trial. Depending how the full trial is made sometimes one kind of results (positive or negative ones) are more likely to be reported soon, so opening the preliminary data gives a wrong impression that can be different from the end when all tests are finished

0 ( +0 / -0 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites